I'll start with your last question on the TRIPS waiver.
Based on the limited knowledge I have of the agreements that have been made public in other countries, my really strong guess is that Canada has pretty much agreed that we're not going to invoke something like that in our agreements, if we ever get to see them.
I think that if you're going send a message that we're open to pharmaceutical investment, siding with that kind of a waiver would not be a good way of getting people who already have those concerns to want to come and invest in Canada. I think we've struck the balance about right.
In terms of your first question, I think we have to figure out a way to get within the American supply chain in a more constructive way. As I said, my own view of this is we should have bought our way into Operation Warp Speed. We didn't, but we should be looking at those kinds of opportunities to be formally part of what the Americans are doing. I think that's the way we make progress.